Synapse - Helen Won

Results (109)

Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer

Journal Article

Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma

Meeting Abstract

Jordan, E.; Won, H.; Toubaji, A.; Bagrodia, A.; Desai, N.; Bajorin, D.; Rosenberg, J.; Bochner, B.; Kim, W.; Berger, M.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Molecular signature of patients with pre-treated urothelial carcinoma (UC) achieving extreme responses to pazopanib (PZP) salvage therapy

Meeting Abstract

Pinciroli, P.; Iyer, G.; Won, H. H.; Canevari, S.; Colecchia, M.; De Braud, F. G.; Daidone, M. G.; Giannatempo, P.; Raggi, D.; Pennati, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)

Meeting Abstract

Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)

Journal Article

Hechtman, J. F.; Liu, W.; Sadowska, J.; Zhen, L.; Borsu, L.; Arcila, M. E.; Won, H. H.; Shah, R. H.; Berger, M. F.; Vakiani, E.; more...
Modern Pathology (2015)

Fulltext@MSK | Save

A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy

Meeting Abstract

Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor

Journal Article

Juric, D.; Castel, P.; Griffith, M.; Griffith, O. L.; Won, H. H.; Ellis, H.; Ebbesen, S. H.; Ainscough, B. J.; Ramu, A.; Iyer, G.; more...
Nature (2015)

Fulltext@MSK | Save

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology